nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A phase I study of Topotecan, as a radiosensitizer, for thoracic malignancies
|
Forouzannia, Afshin |
|
2004 |
44 |
1 |
p. 111-119 9 p. |
artikel |
2 |
Bronchial typical carcinoid tumors: histological study of intra- versus extraluminal growth pattern
|
Brokx, Hes A.P. |
|
2004 |
44 |
1 |
p. 129-130 2 p. |
artikel |
3 |
Combined modality treatment for locally advanced non-small cell lung cancer: preoperative chemoradiation does not result in a poorer quality of life
|
Schumacher, Andrea |
|
2004 |
44 |
1 |
p. 89-97 9 p. |
artikel |
4 |
Effectiveness of smoking cessation self-help materials in a lung cancer screening population
|
Clark, Matthew M |
|
2004 |
44 |
1 |
p. 13-21 9 p. |
artikel |
5 |
IASLC Business meeting,Tuesday,August12,203 Vancouver,BC
|
|
|
2004 |
44 |
1 |
p. 131-132 2 p. |
artikel |
6 |
IFC:Paid ad:lung_glaxo_hycamtim_210*280.pdf
|
|
|
2004 |
44 |
1 |
p. IFC- 1 p. |
artikel |
7 |
Instructions to authors
|
|
|
2004 |
44 |
1 |
p. 139-141 3 p. |
artikel |
8 |
K-ras and p16INK4A alterations in sputum of NSCLC patients and in heavy asymptomatic chronic smokers
|
Destro, A |
|
2004 |
44 |
1 |
p. 23-32 10 p. |
artikel |
9 |
Lung cancer patients showing pure ground-glass opacity on computed tomography are good candidates for wedge resection
|
Nakamura, Haruhiko |
|
2004 |
44 |
1 |
p. 61-68 8 p. |
artikel |
10 |
Meeting report 10th world conference of lung cancer August 10-14,2003,Vancouver,Canada
|
|
|
2004 |
44 |
1 |
p. 133-138 6 p. |
artikel |
11 |
Multimodal management of stages IIIāIVa malignant thymoma
|
Bretti, S |
|
2004 |
44 |
1 |
p. 69-77 9 p. |
artikel |
12 |
p53 and FHIT mutations and microsatellite alterations in malignancy-associated pleural effusion
|
Lee, Jin Hwa |
|
2004 |
44 |
1 |
p. 33-42 10 p. |
artikel |
13 |
Postoperative radiotherapy in stage II or IIIA completely resected non-small cell lung cancer: a systematic review and practice guideline
|
Okawara, Gordon |
|
2004 |
44 |
1 |
p. 1-11 11 p. |
artikel |
14 |
pre ix:Calendar of Events
|
|
|
2004 |
44 |
1 |
p. ix- 1 p. |
artikel |
15 |
pre v:Editorial Board
|
|
|
2004 |
44 |
1 |
p. vi-vii nvt p. |
artikel |
16 |
pre vii: Contents
|
|
|
2004 |
44 |
1 |
p. vii- 1 p. |
artikel |
17 |
pre viii: Contents continued
|
|
|
2004 |
44 |
1 |
p. viii- 1 p. |
artikel |
18 |
Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer
|
Narayan, Samir |
|
2004 |
44 |
1 |
p. 79-88 10 p. |
artikel |
19 |
Small lung tumors with the size of 1cm or less in diameter: clinical, radiological, and histopathological characteristics
|
Kishi, Kazuma |
|
2004 |
44 |
1 |
p. 43-51 9 p. |
artikel |
20 |
Towards a minimally invasive staging strategy in NSCLC: analysis of PET positive mediastinal lesions by EUS-FNA
|
Annema, J.T. |
|
2004 |
44 |
1 |
p. 53-60 8 p. |
artikel |
21 |
Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2-overexpressing, untreated, advanced non-small cell lung cancer: report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpressing disease
|
Zinner, Ralph G |
|
2004 |
44 |
1 |
p. 99-110 12 p. |
artikel |
22 |
Weekly administration of irinotecan (CPT-11) plus cisplatin for refractory or relapsed small cell lung cancer
|
Ando, Masahiro |
|
2004 |
44 |
1 |
p. 121-127 7 p. |
artikel |